Shenzhen Kaifa Technology
920029
Shanghai Yongli Belting
300230
Guomai Culture & Media
301052
4
WuHan Hvsen Biotechnology
300871
5
CHANGFU CO.,LTD
871396
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 6.72%318.63M | 37.22%454.7M | -36.64%338.67M | -33.36%333.62M | -44.63%298.57M | -47.40%331.36M | -19.97%534.51M | -20.16%500.66M | -12.26%539.25M | 0.82%629.93M |
Transactional financial assets | ---- | --1.36M | ---- | ---- | -70.41%1.2M | ---- | ---- | 536.96%3.79M | 20.48%4.06M | ---- |
Notes receivable and accounts receivable | 19.09%587.13M | 43.01%588.92M | 12.35%516.99M | 12.47%421.31M | 13.75%493.02M | 10.38%411.8M | -15.43%460.16M | -3.81%374.6M | -1.14%433.4M | -23.11%373.06M |
-Accounts receivable | 19.09%587.13M | 43.01%588.92M | 12.35%516.99M | 12.47%421.31M | 13.75%493.02M | 10.38%411.8M | -15.43%460.16M | -3.81%374.6M | -1.14%433.4M | -23.11%373.06M |
Other receivables (including interest and dividends) | 245.41%51.9M | 86.04%34.76M | 51.80%25.15M | -4.76%16.78M | 3.61%15.03M | 1.16%18.68M | -46.38%16.57M | -19.60%17.62M | -36.98%14.5M | -24.23%18.47M |
-Other receivable | 245.41%51.9M | ---- | 51.80%25.15M | ---- | 3.61%15.03M | ---- | -46.38%16.57M | ---- | -36.98%14.5M | ---- |
Advance payment | -24.78%11.12M | -7.62%23.04M | 205.87%27.37M | 25.86%20.48M | 23.15%14.79M | -3.77%24.94M | -73.75%8.95M | -54.14%16.27M | -36.16%12.01M | -26.60%25.91M |
Inventories | 30.24%689M | 18.49%642.23M | 23.38%674.11M | -13.59%533.49M | -18.63%529.04M | -19.05%542.01M | -16.32%546.37M | -12.87%617.36M | -2.20%650.13M | 19.90%669.54M |
Other current assets | 12.05%62.47M | 5.45%60.88M | -3.40%60.46M | -23.43%46.73M | -3.20%55.76M | -6.61%57.73M | 4.81%62.59M | 4.38%61.03M | -9.11%57.6M | 34.70%61.82M |
Total current assets | 22.23%1.72B | 30.25%1.81B | 0.84%1.64B | -13.76%1.37B | -17.74%1.41B | -22.05%1.39B | -18.12%1.63B | -13.58%1.59B | -6.32%1.71B | 0.12%1.78B |
Non Current assets | ||||||||||
Other equity investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%3.47M |
Investment real estate | -4.00%95.45M | -2.63%96.42M | -3.23%97.39M | -2.62%98.41M | -3.16%99.43M | -22.25%99.02M | -21.71%100.64M | -21.93%101.05M | -21.62%102.67M | -38.73%127.35M |
Long-term equity investment | ---- | --21.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Fixed assets | --1.58B | ---- | -2.10%1.51B | ---- | ---- | ---- | -0.20%1.54B | ---- | 7.46%1.57B | ---- |
Fixed assets liquidation | ---- | ---- | ---- | ---- | ---- | ---- | -98.61%1.83K | ---- | ---- | ---- |
Constru in process | --34.94M | ---- | -38.34%46.54M | ---- | ---- | ---- | 7.29%75.47M | ---- | -25.67%77.89M | ---- |
Intangible assets | 25.83%304.23M | -6.68%232.56M | -8.94%234.73M | -7.33%235.81M | -6.74%241.78M | -5.39%249.22M | -2.14%257.76M | 2.49%254.45M | -2.52%259.24M | 3.73%263.42M |
Goodwill | 0.00%98.6M | -1.69%98.6M | -1.69%98.6M | -1.69%98.6M | -1.69%98.6M | 0.00%100.3M | 0.00%100.3M | 0.00%100.3M | 0.00%100.3M | -7.23%100.3M |
Long deferred expense | -12.68%49.13M | -12.12%51.64M | -8.59%52.84M | -9.84%54.49M | -3.16%56.27M | 6.21%58.76M | 19.64%57.81M | 26.18%60.43M | 19.78%58.1M | 17.25%55.32M |
Deferred tax assets | -39.70%12.61M | -37.19%9.96M | 2.83%15.82M | 28.02%17.67M | 91.97%20.91M | 336.74%15.86M | 819.20%15.38M | 258.34%13.8M | 178.94%10.89M | 130.13%3.63M |
Usufruct assets | -69.47%521.6K | 6.96%858.43K | 12.90%1.13M | -11.71%1.39M | -4.83%1.71M | --802.55K | --999.96K | --1.57M | --1.8M | ---- |
Other non current assets | -17.87%9.73M | 527.70%11.68M | 321.37%19.86M | -35.21%1.8M | 546.46%11.84M | -91.09%1.86M | -58.13%4.71M | -90.29%2.79M | -83.47%1.83M | 269.08%20.88M |
Total non current assets | 5.04%2.18B | 0.20%2.11B | -3.65%2.07B | -3.91%2.05B | -4.56%2.08B | -3.53%2.11B | -0.80%2.15B | -0.33%2.13B | 2.47%2.18B | 4.10%2.18B |
Total assets | 11.98%3.9B | 12.13%3.92B | -1.72%3.72B | -8.12%3.42B | -10.36%3.49B | -11.85%3.49B | -9.08%3.78B | -6.46%3.72B | -1.59%3.89B | 2.27%3.96B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 44.84%955.53M | 103.99%1.14B | 36.54%897.59M | 17.06%638.77M | 2.64%659.73M | -19.35%557.17M | -26.20%657.4M | -41.82%545.66M | -24.52%642.73M | -28.60%690.84M |
Transactional financial liabilities | 159.53%3.32M | ---- | -87.14%874.12K | 128.35%2.04M | -61.71%1.28M | -38.52%8.5M | 48.33%6.8M | --895.29K | --3.34M | --13.83M |
Notes payable and accounts payable | 44.62%236.9M | -25.74%186.72M | 7.64%224.38M | -42.07%118.38M | -30.50%163.81M | 31.52%251.43M | -48.94%208.45M | -51.17%204.36M | -48.45%235.7M | -34.24%191.18M |
-Notes payable | 17.28%58.21M | -55.17%67.18M | -57.18%55.64M | -77.56%25.21M | -58.38%49.63M | 39.99%149.85M | -55.32%129.96M | -62.81%112.35M | -56.43%119.24M | -41.71%107.04M |
-Accounts payable | 56.51%178.69M | 17.68%119.54M | 114.99%168.74M | 1.26%93.17M | -1.96%114.18M | 20.74%101.58M | -33.11%78.49M | -20.98%92.02M | -36.55%116.45M | -21.43%84.13M |
Contract liabilities | -0.10%313.35K | -71.55%373.36K | 196.71%3.16M | -85.36%694.83K | -95.45%313.66K | -76.38%1.31M | -9.63%1.07M | 141.72%4.75M | 391.67%6.9M | 130.13%5.56M |
Advance receipts | -17.24%3.77M | 269.42%7.13M | 36.38%4.19M | 443.09%7.49M | -10.09%4.56M | -31.61%1.93M | -4.95%3.07M | -32.94%1.38M | -35.46%5.07M | -19.02%2.82M |
Salaries payable | 29.42%118.12M | 16.73%84.79M | 13.73%73.85M | 15.41%65.69M | -0.08%91.27M | 59.34%72.64M | 70.05%64.93M | 40.99%56.92M | 10.28%91.34M | 3.17%45.59M |
Taxs payable | 47.17%39.98M | 53.83%31.38M | 21.35%26.39M | 46.35%28.49M | -10.65%27.17M | -26.53%20.4M | -37.43%21.75M | -10.14%19.46M | 57.39%30.4M | -16.82%27.76M |
Other payable (including interest and dividends) | 224.48%38.69M | -5.19%11.11M | 10.81%10.6M | -10.89%9.13M | 23.55%11.92M | -1.05%11.72M | -31.10%9.56M | -3.36%10.24M | -21.71%9.65M | 0.40%11.85M |
-Other payable | --38.69M | ---- | 10.81%10.6M | ---- | ---- | ---- | -31.10%9.56M | ---- | -21.71%9.65M | ---- |
Non current liabilities due within one year | -92.14%536.17K | -94.68%763.43K | -98.06%4.93M | -97.33%6.69M | -97.28%6.82M | -93.32%14.35M | 2,432.15%253.52M | --250.41M | --250.53M | --214.94M |
Other current liabilities | -93.31%2.14K | -86.40%25.11K | 130.54%378.61K | 121.63%77.98K | -14.17%32.03K | 165.41%184.59K | 133.13%164.23K | -81.74%35.19K | -67.97%37.31K | -63.76%69.55K |
Total current liabilities | 44.50%1.4B | 55.26%1.46B | 1.60%1.25B | -19.80%877.45M | -24.21%966.9M | -21.99%939.63M | -12.68%1.23B | -23.66%1.09B | -10.95%1.28B | -11.03%1.2B |
Current liabilities | ||||||||||
Long term loan | -98.92%822.06K | -99.05%868.86K | -60.76%42.81M | -35.98%76.2M | -35.94%76.27M | -57.15%91.07M | -67.17%109.11M | -44.38%119.02M | -40.94%119.05M | 5.40%212.52M |
Deferred tax liabilities | 160.92%9.78M | -33.01%3.75M | -33.01%3.75M | -33.01%3.75M | -43.30%3.75M | 181.72%5.59M | 189.48%5.59M | 168.77%5.59M | 133.68%6.61M | 39.59%1.99M |
Long term deferred income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -86.17%239.56K |
Lease liabilities | ---- | 241.09%150.71K | 1.29%283.68K | -50.18%346.23K | -33.38%550.71K | --44.18K | --280.08K | --694.9K | --826.66K | ---- |
Total non current liabilities | -86.84%10.6M | -95.07%4.77M | -59.26%46.84M | -35.93%80.29M | -36.30%80.57M | -54.97%96.71M | -65.65%114.99M | -42.20%125.31M | -38.44%126.49M | 4.87%214.75M |
Total liabilities | 34.40%1.41B | 41.23%1.46B | -3.62%1.29B | -21.46%957.74M | -25.30%1.05B | -26.98%1.04B | -22.88%1.34B | -26.10%1.22B | -14.40%1.4B | -8.94%1.42B |
Shareholders equity | ||||||||||
Paid-in capital | -0.02%369M | 0.00%369.08M | 0.00%369.08M | -3.20%369.08M | -3.20%369.08M | -3.20%369.08M | -3.20%369.08M | -2.97%381.26M | -2.97%381.26M | -2.97%381.26M |
Capital reserve funds | 2.47%1.52B | 2.47%1.52B | 0.00%1.49B | -5.58%1.49B | -5.58%1.49B | -5.59%1.49B | -5.59%1.49B | -6.52%1.57B | -6.52%1.57B | -4.31%1.58B |
Surplus reserve funds | 19.69%115.44M | 25.70%96.45M | 25.70%96.45M | 25.70%96.45M | 25.70%96.45M | 25.01%76.73M | 25.01%76.73M | 25.01%76.73M | 25.01%76.73M | 17.69%61.38M |
Retained profit | 28.70%643.17M | 11.71%600.43M | 24.54%573.81M | 10.51%581.99M | 2.44%499.76M | 5.38%537.51M | 7.22%460.76M | 38.16%526.64M | 63.34%487.87M | 58.50%510.08M |
Less:Treasury stock | 2,879.05%129.99M | 2,192.33%100.03M | 1,467.16%68.38M | -37.44%23.81M | -88.54%4.36M | 28.06%4.36M | 28.06%4.36M | -63.11%38.06M | -46.52%38.06M | -92.43%3.41M |
Other composite income | -188.24%-24.58M | -265.53%-37.78M | -166.74%-34.06M | -170.16%-47.48M | -268.74%-8.53M | -158.54%-10.33M | 314.13%51.04M | 79.69%-17.57M | 109.75%5.05M | 133.12%17.66M |
Shareholders equity without minority interests | 2.35%2.5B | -0.15%2.45B | -0.67%2.42B | -1.62%2.46B | -1.94%2.44B | -3.40%2.46B | 0.83%2.44B | 7.44%2.5B | 7.48%2.49B | 9.83%2.54B |
Total shareholder equity | 2.35%2.5B | -0.15%2.45B | -0.67%2.42B | -1.62%2.46B | -1.94%2.44B | -3.40%2.46B | 0.83%2.44B | 7.44%2.5B | 7.47%2.49B | 9.83%2.54B |
Total liabilityies and equity | 11.98%3.9B | 12.13%3.92B | -1.72%3.72B | -8.12%3.42B | -10.36%3.49B | -11.85%3.49B | -9.08%3.78B | -6.46%3.72B | -1.59%3.89B | 2.27%3.96B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.